Schedule 13G ownership disclosure
ESPERION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 29664W105
Event date: 2021-12-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,714,286
- Percent of class
- 9.1300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-21-000104
- Form type
- SC 13G
- Filer
- Esperion Therapeutics, Inc.
- CIK
- CIK 1434868
- Filed
- Dec 09, 2021
- Reporting period
- Dec 03, 2021
- Description
- Schedule 13G beneficial ownership